Time: May 18, 2016 from 1pm to 2pm
Location: Online Webinar - Eastern Time Zone
Website or Map: http://www.readytalk.com/
Phone: 1.866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: May 16, 2016
Export to Outlook or iCal (.ics)
MySpace
Tweet
Wednesday, May 18th at 1pm eastern
Please join PPMD and FibroGen as we host a webinar Wednesday, May 18th at 1PM ET to discuss FibroGen’s investigational drug FG-3019 (which is an anti-CTGF monoclonal antibody) and the launch of FibroGen’s MissionDMD program that is currently being conducted to investigate FG-3019 in Duchenne muscular dystrophy. Specifically, this presentation will provide the rationale for evaluating FG-3019 in Duchenne patients and a description of the ongoing clinical trial in non-ambulatory boys with Duchenne.
Speakers:
To Participate:
Submit Questions:
Please submit questions in advance to info@parentprojectmd.org, with “FibroGen Webinar” in the subject line by noon on Monday, 5/16.
© 2023 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
RSVP for [Upcoming Webinar] MissionDMD: FibroGen’s Anti-Fibrosis Program to add comments!
Join PPMD Community